Concepedia

Sowmya Parampalli Yajnanarayana

SP

Statistics

Publications

4

Citations

723

H-Index

4

Active since

2013

Affiliations

University Hospital Bonn(Current)

Tyrolean Cancer Research Institute

Sowmya Parampalli Yajnanarayana is an author at University Hospital Bonn specializing in immunology, life sciences, and jak inhibitors.

Publications per year

2013–2021

4

Publications

4

The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo

Annkristin Heine, Stefanie Andrea Erika Held, Solveig Nora Daecke et al. · Blood · 2013 · 345 citations · Full text

Life Sciences, Immunology, Pharmacology +10

JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms

Kathrin Schönberg, Janna Rudolph, Maria Vonnahme et al. · Cancer Research · 2015 · 179 citations

Life Sciences, Immunology, Pharmacology +17

JAK1/2 inhibition impairs T cell function <i>in vitro</i> and in patients with myeloproliferative neoplasms

Sowmya Parampalli Yajnanarayana, Thomas Stübig, Isabelle Cornez et al. · British Journal of Haematology · 2015 · 159 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Tumor rejection in <i>Cblb</i> <sup>−/−</sup> mice depends on IL-9 and Th9 cells

Oliver Schanz, Isabelle Cornez, Sowmya Parampalli Yajnanarayana et al. · Journal for ImmunoTherapy of Cancer · 2021 · 40 citations · Full text

Life Sciences, Immunology, Oncology +16

1–4 of 4